Bioscience prominent in 2012 class of Great Ohioans

Dr. Albert Sabin

Albert Sabin, MD,  and Gordon Battelle are among six Great Ohioan honorees named last week by the Capitol Square Review and Advisory Board and Capitol Square Foundation in Columbus.

A former distinguished professor of pediatrics at the University of Cincinnati College of Medicine and researcher at Cincinnati Children’s Hospital, Sabin is best known for his pioneering work in developing the oral, live polio vaccine that helped eliminate polio from most countries.

Gordon Battelle

Gordon Battelle was the son of a well-known industrialist and a budding metallurgist/entrepreneur who died too soon at age 40, following an appendectomy. Through his will, he established the Battelle Memorial Institute “for the purpose of education in connection with and the encouragement of creative and research work and the making of discoveries and inventions.” Today, Battelle is the world’s largest independent research and development organization providing innovative solutions to the world’s most pressing needs.

Honorees and their achievements are featured in a permanent exhibit in the Ohio Statehouse Museum. The other recipients this year are Dominic Salvatore Gentile, World War II fighter pilot; Washington Gladden, clergyman and social reformer; Albert Belmont Graham, founder of the 4-H program; and Gen. William T. Sherman.

Between 1953 and 1960, Sabin worked in his Cincinnati laboratories developing the polio vaccine. His live virus vaccine could be given by mouth via a spoon or on a sugar cube and was believed to give a stronger immunity than the injected killed-virus vaccine, developed previously by Jonas Salk, MD. The stronger immunity and the ease of administering the oral vaccine, made Sabin’s vaccine far superior.

“Few people have had as significant a worldwide impact as Dr. Sabin,” Thomas Boat, MD, dean of the UC College of Medicine, wrote in his letter nominating Sabin for the Great Ohioan recognition. “The fact that younger generations in the United States and many areas of the world are unaware of polio and its devastating effects is the greatest testament to his success and impact.”

Tests in 1959 with more than 10 million Russian children and the administration of the vaccine to more than 180,000 children in Greater Cincinnati in 1960 – which many people remember as “Sabin Sundays” – helped prove the success of Sabin’s vaccine. The Sabin oral vaccine was ultimately selected for worldwide distribution.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

Porter Wright getting new managing partner, Bob Tannous will take over for Robert Trafford | Columbus Business First, October 22, 2014

Cardinal Health donates one million medical products to help fight Ebola in West Africa | The Columbus Dispatch, October 21, 2014

Procter & Gamble hiring soon for distribution center in Union’s Global Logistics Airpark | WDTN2 News, October 21, 2014

Central Ohio career technical education partnerships are shaping tomorrow’s workforce today | Columbus CEO, October 21, 2014

NanoLogix developing rapid test for Ebola virus (video) | WYTV33 Youngstown, October 21, 2014

Analytic, a partnership of Anatrace and Microlytic: enabling membrane protein research | PR Web, October 21, 2014

Quasar Energy Group uses organic waste to produce renewable energy | Todays Energy Solutions, October 21, 2014

Frank Samuel, President of VentureOhio and former BioOhio President dies in auto accident | Geauga County Maple Leaf, October 21, 2014

Milo Biotechnology’s follistatin gene therapy increases function in Becker Muscular Dystrophy patients | PR Newswire, October 20, 2014

Skilled Care Pharmacy and Assurex Health announce partnership to provide GeneSight genetic test | Assurex Health, October 20, 2014

Mayo Clinic and Cleveland Clinic latest to deploy HealthSpot telemedicine booths | Columbus Business First, October 20, 2014

OSU Wexner Medical Center study: new implantable device to control heart failure shows promising results | Todays Medical Developments, October 17, 2014

Assurex Health gets $6M funding for clinical trial related to patients with depression or schizophrenia | Cincinnati Business Courier, October 17, 2014

University of Cincinnati lands grant to attack hepatitis C among needle users in 20 counties | WCPO9 Cincinnati, October 16, 2014

Control Bionics interview, developing technology that enables individuals with debilitating conditions to communicate | The Clermont Sun, October 16, 2014

BioOhio member Oralectrics spinout Zumby opens crowdfunding campaign | Cleveland.com, October 16, 2014

Ohio State sophomore Peeyush Shrivastava of Genetesis named a finalist in $5M 43North business plan competition | Columbus Business First, October 16, 2014

Navidea hires Rick Gonzalez as CEO from Spectrum Pharmaceuticals, replaces Michael Goldberg, Navidea’s lead investor | Columbus Business First, October 15, 2014

Health Care DataWorks’ Chief Data Scientist to present at healthcare conference sponsored by HIMSS Georgia Chapter | PR Web, October 15, 2014

FDA approves expanded use of Navidea’s Lymphoseek for lymphatic mapping in solid tumors | Business Wire, October 15, 2014